Literature DB >> 11150074

Control of intra-ocular inflammation associated with cataract surgery.

S M El-Harazi1, R M Feldman.   

Abstract

Postoperative ocular inflammation following cataract surgery is related to the risk of complications like corneal edema, intraocular pressure spikes, cystoid macular edema, and posterior capsule opacification. The degree of postoperative inflammation following cataract surgery is linked to several surgery-dependent factors such as surgical technique, intraocular lens type, and also patient-dependent factors such as history of inflammatory disease and degree of iris pigmentation. During the past decade, major advances have occurred in cataract surgery techniques, equipment, and pharmacologic strategies that decrease the degree of postoperative inflammation following cataract surgery and reduce patients' risk for inflammation-related complications. This article reviews the most recent literature regarding the control of cataract surgery-induced intra-ocular inflammation.

Entities:  

Mesh:

Year:  2001        PMID: 11150074     DOI: 10.1097/00055735-200102000-00002

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  35 in total

1.  Changes in the tear film and ocular surface after cataract surgery.

Authors:  Taehoon Oh; Younhea Jung; Dongjin Chang; Jaeryun Kim; Hyunseung Kim
Journal:  Jpn J Ophthalmol       Date:  2012-03       Impact factor: 2.447

Review 2.  Bromfenac Ophthalmic Solution 0.07%: A Review of Its Use After Cataract Surgery.

Authors:  Sheridan M Hoy
Journal:  Clin Drug Investig       Date:  2015-08       Impact factor: 2.859

3.  Comparison of postoperative corneal changes between dry eye and non-dry eye in a murine cataract surgery model.

Authors:  Jin Woo Kwon; Yeon Woong Chung; Jin A Choi; Tae Yoon La; Dong Hyun Jee; Yang Kyung Cho
Journal:  Int J Ophthalmol       Date:  2016-02-18       Impact factor: 1.779

4.  Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation.

Authors:  L David Waterbury; Danielle Galindo; Linda Villanueva; Cathy Nguyen; Milan Patel; Lisa Borbridge; Mayssa Attar; Rhett M Schiffman; David A Hollander
Journal:  J Ocul Pharmacol Ther       Date:  2011-02-25       Impact factor: 2.671

Review 5.  Loteprednol etabonate ophthalmic gel 0.5%: a review of its use in post-operative inflammation and pain following ocular surgery.

Authors:  Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

6.  Comparison of the anti-inflammatory effects of fluorometholone 0.1% combined with levofloxacin 0.5% and tobramycin/dexamethasone eye drops after cataract surgery.

Authors:  Pei-Qing Chen; Xue-Mei Han; Ya-Nan Zhu; Jia Xu
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

Review 7.  Clinical Applications of Dexamethasone for Aged Eyes.

Authors:  Beatriz Abadia; Pilar Calvo; Antonio Ferreras; Fran Bartol; Guayente Verdes; Luis Pablo
Journal:  Drugs Aging       Date:  2016-09       Impact factor: 3.923

Review 8.  Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use.

Authors:  Michael Amon; Massimo Busin
Journal:  Int Ophthalmol       Date:  2012-06-16       Impact factor: 2.031

9.  Effect of intraocular surgery and ketamine on aqueous and serum cytokines.

Authors:  Kyaw Lin Tu; Stephen B Kaye; Gediminas Sidaras; William Taylor; Alan Shenkin
Journal:  Mol Vis       Date:  2007-07-12       Impact factor: 2.367

10.  Loteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial.

Authors:  Raymond Fong; Martin Leitritz; Raphaele Siou-Mermet; Tara Erb
Journal:  Clin Ophthalmol       Date:  2012-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.